TAKE Solutions' Announces Release of PharmaReady Version 4.1
TAKE Solutions' Life Sciences division announced today the release of PharmaReady Version 4.1 that offers new enhancements to the fully integrated, Web-based suite of products.
TAKE Solutions’ Life Sciences Division Announces Release of PharmaReady Version 4.1
Raleigh, N.C. – October 28, 2008 -TAKE Solutions’ Life Sciences division announced today the release of PharmaReady Version 4.1 that offers powerful new enhancements to the fully integrated, web-based suite of products.
The industry-leading document management and submissions publishing solution, built on Microsoft platform, is deployed at customer sites worldwide. “Since its launch in 2003, PharmaReady has been continuously evolving to meet the demands of the regulated life sciences industry. Five years and scores of satisfied customers later, our focus still remains the same,” states Robert MacDougall, Executive Vice President, TAKE Solutions.
With continuous inputs from its customers, TAKE Solutions has been creating newer modules and features to PharmaReady, furthering the effectiveness and easy-of-use of the solution suite. Some of the highlights of the PharmaReady 4.1 are:
PharmaReady V4.1 Highlights:
Document Management System (DMS)
-Virtual Document Workflow and Interface Enhancements
-Enhanced Office 2007 Integration and Support
-Document Owner Functionality and Role
Electronic Submissions (eCTD)
-eCTD Enhanced Support for Canadian STF Submissions
-Increased eCTD Support for STF Sub-Structures
-Enhanced Acrobat Support
-eCTD Submission Compile Time Decrease and Enhancements
-Support for Updated eCTD Guidance from FDA
Training Records Management System (TRMS)
-Option to Add TRMS Events Directly to Outlook Calendar
-Enhanced Action Item Processing
Structured Product Labeling (SPL)
-Workflow Notifications can be turned off / on
-Updated Scripts to Better Support FDA Guidelines
About PharmaReady™PharmaReady is a fully integrated web-based product and services solution suite including Document Management, Training Records Management, Structured Product Labeling and Submission Services. PharmaReady is specifically designed for life science organizations where ease of installation, ease of use, Part 11 compliance, and affordability are the primary business drivers. The PharmaReady solution suite is designed for management of SOPs, work instructions, training records, submission documents and all other documents within business areas regulated by the FDA. PharmaReady is a fully 21 CFR Part 11 compliant solution based on Microsoft Windows technology.
About TAKE Solutions
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise in Life Sciences and Supply Chain Management, to provide cost-effective, comprehensive solutions for businesses. The vision of the company is to drive industry best practices through our proprietary, in-depth product know-how and solutions that enable business efficiencies for our clients. Since its inception in 2000, TAKE has been serving marquee clients in the Life Sciences and SCM arena. TAKE Solutions conducts business today in 16 countries with more than 300 customers.
Headquartered in Chennai, TAKE has a strong presence in the USA with Life Sciences Domain Excellence centers located in Princeton, New Jersey. TAKE Solutions is assessed at Level 5 of the Capability Maturity Model Integration (CMMI), Software Engineering Institute, Carnegie Mellon University, USA. TAKE Solutions is a Microsoft Gold Certified Partner, a Charter Member of the Microsoft BioIT Alliance, and is a Registered CDISC Solution Provider.www.TAKESolutions.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
